Wood shares 3 factors that influencing our nationally poor rates of high-risk lung cancer screening.
Douglas Wood, MD
Advertisement
Articles by Douglas Wood, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
EADV Congress 2026: Day 3 Recap—5 Headlines to Know
2
EADV 2026: Telikibart Attains EASI-75 in 70% at Week 16 in Atopic Dermatitis
3
AMETHYST: Litifilimab Sustains CLE Gains at 52 Weeks, With Victoria Werth, MD
4
Upadacitinib Tops Nemolizumab on Skin, Itch Targets in Indirect Analysis
5